Aakha
<UNKNOWN> · 1 known investors
Aakha Bio develops multi-specific antibodies for solid tumors that block disease pathways and activate immune cells. The company targets cancer patients with limited treatment options using a platform approach that integrates multiple therapeutic mechanisms into single molecules.
BiotechHealthtechMedical Devices
Founders & leadership
HB
Hemanta BaruahFounder & CEO
Investors · 1
In the news
- Aakha Biologics has filed a notice of an exempt offering of securities to raise $5 Million in New Debt Financing. - intelligence360intelligence360.news · 2024
- Aakha.bio - 2026 Company Profile, Funding & Competitors - Tracxntracxn.com · 2023
- Aakha Biologics Relocates from BioLabs Pegasus Park to Permanent North Texas HQ in Frisco » Dallas Innovatesdallasinnovates.com · 2022